Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-28
Closed -$3.36K 3161
2022
Q4
$3.36K Buy
+28
New +$4.46K ﹤0.01% 2758
2022
Q1
Sell
-263
Closed -$104K 3987
2021
Q4
$104K Buy
263
+219
+498% +$126K ﹤0.01% 4052
2021
Q3
$31K Sell
44
-245
-85% -$187K ﹤0.01% 4160
2021
Q2
$278K Buy
+289
New +$261K ﹤0.01% 3570
2021
Q1
Sell
-151
Closed -$114K 4176
2020
Q4
$114K Buy
151
+107
+243% +$91.5K ﹤0.01% 3203
2020
Q3
$42K Buy
+44
New +$42.7K ﹤0.01% 2982
2015
Q2
Hold
0
-$32K 3034
2015
Q1
Hold
0
2590
2014
Q4
Hold
0
2186
2014
Q3
Hold
0
1702

Other funds holding CNSY

John Overdeck's CNSY Position: Q1 2023 in Review

John Overdeck sold out of Cerenome (CNSY) in Q1 2023, closing a stake of 28 shares — an estimated $3.36K sold.

John Overdeck first reported a position in CNSY in Q3 2020 and held it in 6 quarters. The position peaked at $278K in Q2 2021. 16 funds tracked by Wall St. Rank hold CNSY as of Q1 2023.

  • John Overdeck reported no remaining Cerenome position as of Q1 2023 after selling out during the quarter.
  • John Overdeck sold 28 Cerenome shares in Q1 2023, an estimated $3.36K.
  • John Overdeck first reported a position in Cerenome in Q3 2020 and held it in 6 quarters.
  • John Overdeck's Cerenome position peaked at $278K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Cerenome as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.